LIMN - Liminatus Pharma, Inc. Common Stock

Liminatus Pharma, Inc. (LIMN)

NGM · Common · CUSIP 53271X108

Last Price•••.••

Current Yield•.••%

Yield to Call•.••%

Yield to Worst•.••%

Free registration unlocks the quote, yield calculations, price chart and full fundamentals for LIMN and every other security on QuantumOnline.

Overview Financials 🔒 Earnings 🔒 Dividends 🔒 Analysts 🔒 Ownership 🔒 ESG 🔒 Technicals 🔒

🔒

Price chart and 15 days of daily prices

Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Links: Home Page

Business: iLiminatus Pharma, Inc. s a pre-clinical stage biopharmaceutical company focused on developing novel cancer immunotherapies.